• 1.

    Coca SG, et al.. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. J Am Med Assoc 2006; 296:13771384.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006; 70:20212030.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Konstantinidis I, et al.. Representation of patients with kidney disease in trials of cardiovascular interventions: An updated systematic review. JAMA Intern Med 2016; 176:121124.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Ishida JH, Johansen KL. Exclusion of patients with kidney disease from cardiovascular trials. JAMA Intern Med 2016; 176:124125.

Kidney Health Initiative Project Explores Cardiovascular Clinical Trials for People with Kidney Diseases

Restricted access

Kidney disease is common in people with cardiovascular disease (1, 2), and managing cardiovascular disease in people with kidney diseases is an important clinical problem. However, the evidence to support optimal management is hampered by the continual exclusion of people with kidney diseases from cardiovascular trials (14). In order to understand this problem and determine potential solutions, a Kidney Health Initiative (KHI) project aims to identify the barriers to involving people with kidney diseases—with a focus on those with advanced chronic kidney disease (stage 4) and end stage renal disease—in cardiovascular trials

Save